Skip to content

Sharp offer well-established QP services, helping to streamline your product’s journey to trial and market in the EU and giving you and your customers confidence that your products have been manufactured to the very highest standards.

QP Release Services

Once a satisfactory audit is complete, your Sharp QP will issue a declaration that you can use to submit your Clinical Trial Authorisation (CTA). We can then work with you to manage the storage and distribution of your clinical trial supplies to your testing sites.

The Role of a (QP) Qualified Person

It is a requirement within the EU that all investigational and medicinal products manufactured or imported by organisations holding a MA IMP, have a QP to approve and release each batch of IMP for usage in clinical trials. QPs have gained personal knowledge of the quality systems used at the manufacturing site, usually through an EU Good Manufacturing Practice Audit.

QPs are assigned projects according to their specialist expertise and have personal and legal responsibility as defined by the EU Clinical Trial Directive (2001/20/EC).

Talk to our expert team today about your QP release needs.

Related Resources

Are you attending Korea Pharm & Bio in April?
Connect with Sharp to see how we can help you engineer the best #packagingsolutions for #productlaunch in the US and EU market. #SharpServices #pharmapackaging #biotech #coldchain #serialization

Another big milestone for our #ClinicalServices team in the US with the news that Sharp Bethlehem has concluded a successful FDA audit. Watch our video to learn about #SharpClinical - your partner of choice for end-to-end supply chain solutions.
#ClinicalTrials #OurWorkMatters

UDG Healthcare CEO Awards – Celebrating excellence and recognising our people. @UDGHealthcare #CEOAwards #LivingOurValues